A nonprofit pharmacy that specializes in supplying prescription medications to the uninsured in the US Good Shepherd Pharmacy teamed up with the FedEx Institute of Technology in a unique cancer blockchain project.
The companies are developing a blockchain-based system that will give patients experiencing cancer an equal chance to receive probably life-altering drugs. The project will be situated in Memphis, TN, beside the Good Shepherd, and was made available all over the country.
The main goal of the project is to accumulate unused medications from cancer patients for distribution to others who cannot afford to buy their own. With the use of blockchain, this action will be improved, providing a secure distribution and reduced costs of operation.
Phil Baker, the CEO of Good Shepherd, stated:
“The REMEDI project (REclaiming MEDicine) will divert valuable medication into the hands of patients who would not otherwise use it.”
FedEx Institute will set up an event with Blockchain 901, which concentrates on expanding Memphis’ technology workforce. The event will allow blockchain enthusiasts and professionals the chance to unite and discuss the challenges of Good Shepherd’s blockchain resource development program.
Meanwhile, a pharmaceutical giant Merck has filed for a patent covering a system to fight artificial medicine using the blockchain.